STOCK TITAN

Zodiac Partners files amended tender offer for Destination XL (NASDAQ: DXLG)

(Neutral)
(Neutral)
Form Type
SC TO-T/A

Rhea-AI Filing Summary

Destination XL Group, Inc. is the subject of a cash tender offer by Zodiac Partners II, LLC (an acquisition entity of Camac Fund) to purchase all outstanding shares at $0.82 per share, payable in cash, less required withholding taxes. The offer is set forth in an Offer to Purchase originally dated May 12, 2026 and is reported here in Amendment No. 2, with related exhibits including an Equity Commitment Letter and a confidential-term Revolving Credit Facility term sheet.

Positive

  • None.

Negative

  • None.

Insights

Legal structure: a third‑party cash tender offer at a fixed per‑share price.

The filing describes a cash tender offer to purchase all outstanding common shares of Destination XL Group, Inc. at $0.82 per share, governed by the Offer to Purchase and Letter of Transmittal. Key governance and approval items are referenced in Section 12 of the Offer, including statutory and merger‑approval topics.

Monitor formal conditions listed in Section 14 and Section 15 for regulatory or legal prerequisites; timing and effectiveness conditions are set in the Offer documents attached as exhibits.

Financing appears supported by an equity commitment and a proposed $75 million revolving facility term sheet.

The exhibits include an Equity Commitment Letter and an indicative $75 million Revolving Credit Facility Term Sheet, with confidential portions redacted. These items identify the contemplated funding sources described in Section 10.

Cash‑flow treatment and lender conditions are in the attached term sheet; subsequent filings will reveal committed debt capacity and any material covenants affecting close.

Offer price $0.82 per share cash tender offer to purchase all outstanding common shares
Revolving Credit Facility (indicative) $75 million indicative term sheet included as an exhibit
Offer date (original) May 12, 2026 Offer to Purchase originally dated
Amendment filing date June 2, 2026 Amended Offer to Purchase dated and Exhibit (a)(1)(A)
Tender Offer financial
"This Schedule TO relates to the offer by the Purchaser to purchase all outstanding shares"
A tender offer is a proposal made by a person or company to buy shares from existing shareholders at a set price, usually higher than the current market value, within a specific time frame. It matters to investors because it can lead to a change in ownership or control of a company, and shareholders must decide whether to sell their shares at the offered price.
Letter of Transmittal regulatory
"Offer to Purchase and in the accompanying Letter of Transmittal"
A letter of transmittal is a written form investors use when sending physical stock certificates or electronic ownership documents to a company or its agent to surrender shares, tender them in an offer, or claim payment or replacement securities. It acts like a packing slip that lists what is enclosed, gives instructions on how the transfer should be handled, and provides proof of the transaction—important for ensuring investors receive the correct payment or new securities without delay or dispute.
Equity Commitment Letter financial
"Exhibit (d) Equity Commitment Letter between Zodiac Partners II, LLC and Camac Fund LP"
A written promise from an investor or group to provide a specified amount of capital for a deal, such as an acquisition or a new financing round. It matters to investors because it shows how likely a transaction is to close and how much fresh money will be available, similar to a down-payment commitment when buying a house: the stronger the promise, the less risk that the deal will fall apart or that existing shareholders will face unexpected dilution.
Revolving Credit Facility Term Sheet financial
"Indicative $75 million Revolving Credit Facility Term Sheet (confidential portions requested)"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What price is Zodiac Partners II offering for DXL (DXLG)?

The offer price is $0.82 per share. The Offer to Purchase dated May 12, 2026 and accompanying Letter of Transmittal set forth the terms and payment is in cash, less any required withholding taxes.

Who is making the tender offer for Destination XL (DXLG)?

The offeror is Zodiac Partners II, LLC, an acquisition entity of Camac Fund, LP. The Schedule TO identifies Zodiac Partners II as the Purchaser and Camac Fund as the parent of the offeror.

What funding sources are disclosed for the DXLG tender offer?

Exhibits include an Equity Commitment Letter and an indicative $75 million Revolving Credit Facility Term Sheet. Section 10 of the Offer to Purchase addresses the source and amount of funds behind the transaction.

Does Amendment No. 2 report results or change terms of the offer for DXLG?

Amendment No. 2 is identified as a filing to the Schedule TO and states it is an amendment to the Offer; the Amended Offer to Purchase dated June 2, 2026 is included as an exhibit to reflect the current Offer terms.

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

AMENDMENT NO. 2 TO

SCHEDULE TO

 

Tender Offer Statement Under Section 14(d)(1) or 13(e)(1)

of the Securities Exchange Act of 1934

 

Destination XL Group, Inc.

(Name of Subject Company)

 

Zodiac Partners II, LLC

(Name of Filing Person (Offeror))

 

Camac Fund, LP

(Name of Filing Person (Parent of Offeror))

 

Common Stock, par value $0.01 per share

(Title of Class of Securities)

 

25065K104

(CUSIP Number of Class of Securities)

 

Craig Rosmarin

Chief Financial Officer

1601-1 N Main St #3159, SMB#92283, Jacksonville, FL 32206

(917) 692-1844

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications on

Behalf of Filing Persons)

 

Copies to:

Donald R. Reynolds

Wyrick Robbins Yates & Ponton LLP

4101 Lake Boone Trail, Suite 300

Raleigh, NC 27607

(919) 781-4000

 

 ☐ Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.

 

Check the appropriate boxes below to designate any transactions to which the statement relates:

 

  third-party tender offer subject to Rule 14d-1.
     
  issuer tender offer subject to Rule 13e-4.
     
  going-private transaction subject to Rule 13e-3.
     
  amendment to Schedule 13D under Rule 13d-2.

 

Check the following box if the filing is a final amendment reporting the results of the tender offer.  ☐

 

If applicable, check the appropriate box(es) below to designate the appropriate rule provision(s) relied upon:

 

  Rule 13e-4(i) (Cross-Border Issuer Tender Offer)
     
  Rule 14d-1(d) (Cross-Border Third-Party Tender Offer)

 

 

 

 
 

 

This Amendment No. 2 to Tender Offer Statement on Schedule TO (this “Schedule TO”) is filed by Camac Fund, LP, a Delaware limited partnership (“Camac Fund”), and Zodiac Partners II, LLC, a Delaware limited liability company (the “Purchaser”, “Zodiac Partners II, LLC”) and an acquisition entity of Camac Fund. This Schedule TO relates to the offer by the Purchaser to purchase all outstanding shares of common stock, par value $0.01 per share (the “Shares”), of Destination XL Group, Inc., a Delaware corporation (“DXL”), at $0.82 per Share, to the seller in cash, without interest and less any required withholding taxes, upon the terms and subject to the conditions set forth in the Offer to Purchase, originally dated May 12, 2026 (the “Offer to Purchase”), and in the accompanying Letter of Transmittal, copies of which are attached hereto as Exhibits (a)(1)(A) and (a)(1)(B), respectively, which, together with any amendments or supplements thereto, collectively constitute the “Offer”.

 

Item 1. Summary Term Sheet.

 

The information set forth in the Offer to Purchase under the caption SUMMARY TERM SHEET is incorporated herein by reference.

 

Item 2. Subject Company Information.

 

(a) The name, address, and telephone number of the subject company’s principal executive offices are as follows:

 

Destination XL Group, Inc.

555 Turnpike Street

Canton, MA 02021

 

(b) This Schedule TO relates to the Offer by the Purchaser to purchase all of the issued and outstanding Shares. According to DXL’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 19, 2026 (the “DXL FY2025 Form 10-K”), as of March 9, 2026 there were 54,810,511 Shares issued and outstanding, and based on the Purchaser’s review of the DXL FY2025 Form 10-K, we believe as of January 31, 2026, there were approximately 44,000 stock options to purchase Shares, and 1,259,000 restricted stock units outstanding.

 

(c) The information set forth under the caption THE OFFER - Section 6 (“Price Range of Shares; Dividends”) and Section 11 (“Background of the Offer”) of the Offer to Purchase is incorporated herein by reference.

 

Item 3. Identity and Background of Filing Person.

 

(a)-(c) The filing companies of this Schedule TO are (i) Camac Fund LP, and (ii) the Purchaser, Zodiac Partners II, LLC. The information set forth in the Offer to Purchase under the following captions is incorporated herein by reference:

 

SUMMARY TERM SHEET

 

THE OFFER - Section 9 (“Certain Information Concerning the Purchaser, Zodiac Partners II, LLC, and Camac Fund, LP”) and Schedule I attached thereto.

 

Item 4. Terms of the Transaction.

 

(a)(1)(i)-(viii), (x), (xii), (a)(2) The information set forth in the Offer to Purchase is incorporated herein by reference.

 

Subsections (a)(1)(ix) and (xi) are not applicable.

 

 
 

 

Item 5. Past Contacts, Transactions, Negotiations and Agreements.

 

(a), (b) The information set forth in the Offer to Purchase under the following captions is incorporated herein by reference:

 

SUMMARY TERM SHEET

 

INTRODUCTION

 

THE OFFER - Section 9 (“Certain Information Concerning the Purchaser, Zodiac Partners II, LLC, and Camac Fund, LP”) and Schedule I attached thereto

 

THE OFFER - Section 10 (“Source and Amount of Funds”) and Schedule I attached thereto

 

THE OFFER - Section 11 (“Background of the Offer”)

 

THE OFFER - Section 12 (“Purpose of the Offer and the Proposed Merger; Plans for DXL; Statutory Requirements; Approval of the Proposed Merger”)

 

Item 6. Purposes of the Transaction and Plans or Proposals.

 

(a) The information set forth in the Offer to Purchase under the following captions is incorporated herein by reference:

 

SUMMARY TERM SHEET

 

INTRODUCTION

 

THE OFFER - Section 12 (“Purpose of the Offer and the Proposed Merger; Plans for DXL; Statutory Requirements; Approval of the Proposed Merger”)

 

(c) (1)-(7) The information set forth in the Offer to Purchase under the following captions is incorporated herein by reference:

 

SUMMARY TERM SHEET

 

INTRODUCTION

 

THE OFFER - Section 7 (“Possible Effects of the Offer on the Market for the Shares; Stock Exchange Listing; Registration Under the Exchange Act; Margin Regulations”)

 

THE OFFER - Section 11 (“Background of the Offer”)

 

THE OFFER - Section 13 (“Dividends and Distributions”)

 

Item 7. Source and Amount of Funds or Other Consideration.

 

(a), (b), (d) The information set forth in the Offer to Purchase under the following captions is incorporated herein by reference:

 

SUMMARY TERM SHEET

 

THE OFFER - Section 10 (“Source and Amount of Funds”)

 

THE OFFER - Section 17 (“Fees and Expenses”)

 

 
 

 

Item 8. Interest in Securities of the Subject Company.

 

(a), (b) The information set forth in the Offer to Purchase under the following captions is incorporated herein by reference:

 

THE OFFER - Section 9 (“Certain Information Concerning the Purchaser, Zodiac Partners II, LLC, and Camac Fund, LP”) and Schedule I attached thereto

 

THE OFFER - Section 11 (“Background of the Offer”)

 

Item 9. Persons/Assets, Retained, Employed, Compensated or Used.

 

(a) The information set forth in the Offer to Purchase under the following captions is incorporated herein by reference:

 

SUMMARY TERM SHEET

 

THE OFFER - Section 2 (“Acceptance for Payment and Payment for Shares”)

 

THE OFFER - Section 3 (“Procedure for Tendering Shares”)

 

THE OFFER - Section 11 (“Background of the Offer”)

 

THE OFFER - Section 17 (“Fees and Expenses”)

 

Item 10. Financial Statements.

 

(a) Not applicable.

 

(b) Not applicable.

 

Item 11. Additional Information.

 

(a) The information set forth in the Offer to Purchase under the following captions is incorporated herein by reference:

 

SUMMARY TERM SHEET

 

THE OFFER - Section 7 (“Possible Effects of the Offer on the Market for the Shares; Stock Exchange Listing; Registration Under the Exchange Act; Margin Regulations”)

 

THE OFFER - Section 11 (“Background of the Offer”)

 

THE OFFER - Section 12 (“Purpose of the Offer and the Proposed Merger; Plans for DXL; Statutory Requirements; Approval of the Proposed Merger”)

 

THE OFFER - Section 14 (“Conditions of the Offer”)

 

THE OFFER - Section 15 (“Certain Legal Matters; Regulatory Approvals; Appraisal Rights”)

 

(c)

The information set forth in the Offer to Purchase and the Letter of Transmittal is incorporated herein by reference.

 

 
 

 

Item 12. Exhibits.

 

Exhibit   Description
(a)(1)(A)   Amended Offer to Purchase, dated June 2, 2026.*
(a)(1)(B)   Form of Letter of Transmittal.
(a)(5)(A)   Press Release Issued by Zodiac Partners II, LLC on May 12, 2026.
(d)   Equity Commitment Letter between Zodiac Partners II, LLC and Camac Fund LP, dated May 11, 2026.
(b)   Indicative $75 million Revolving Credit Facility Term Sheet (confidential treatment has been requested for certain portions of this exhibit).
107   Filing Fee Exhibit.
(a)(1)(C)   Notice of Guaranteed Delivery.
(e)   Schedule I.
(a)(1)(F)   W-9 Guidelines.
(a)(1)(E)   Letter to Clients.
(h)   Press Release Issued by Zodiac Partners II, LLC on May 21, 2026.

 

* Asterisk describes exhibits filed herewith. No asterisk means the exhibit has been previously filed.

 

Item 13. Information Required by Schedule 13E-3.

 

Not applicable.

 

 
 

 

SIGNATURE

 

After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: June 2, 2026    
  Zodiac Partners II, LLC
   
  By: /s/ Ziggy Gokea
  Name: Ziggy Gokea
  Title: Managing Member
     
  Camac Fund, LP
   
  By: /s/ Eric Shahinian
  Name: Eric Shahinian
  Title: Manager of GP